Smith & Nephew plc
(NYSE: SNN)
|
4:00 PM EDT, 04/26/24 | |||
---|---|---|---|---|
Last: $24.45 | Change: +0.57 | %Change: +2.39% | Volume: 1,759,851 |
Open: | $ 24.53 | Volume: | 1,759,851 | |
---|---|---|---|---|
High: | $ 24.62 | Yield(%) | 3.06 | |
Low: | $ 24.32 | P/E Ratio (ttm): | 39.54 | |
Dividend ($): | 0.45 | Market Cap ($): | 10.41B | |
EPS ($) | n/a | Shares Out: | 435.97M |
% Price Change (last 4 weeks): | -5.84 |
---|---|
% Price Change (last 13 weeks): | -14.47 |
% Price Change (last 26 weeks): | 10.81 |
% Price Change (last 52 weeks): | -26.18 |
% Price Change (year to date): | -12.46 |
Return on Equity (%): | 5.02 |
---|---|
Return on Assets (%): | 2.64 |
Return on Invested Capital (%): | 5.40 |
Gross Profit Margin (%): | 66.70 |
---|---|
Net Profit Margin (%): | 4.74 |
Operating Profit Margin (%): | 16.89 |
50-day Moving Average: | $26.10 |
---|---|
200-day Moving Average: | $26.42 |
Avg. Daily Vol. (last 50 days): | 926,880 |
Avg. Daily Vol. (last 200 days): | 1,071,559 |
52-wk high: | $33.09 |
52-wk low: | $21.52 |
Bid: | $24.15 |
Ask: | $24.76 |
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
|
Smith & Nephew plc
Croxley Park Hatters Lane Building 5 Watford HR WD18 8YE Phone: 44.1923.477.100 Fax: n/a http://www.smith-nephew.com |
Earnings (1year) ($): | 0.60 |
---|---|
Annual Dividend ($): | 0.73 |
Current P/E Ratio (ttm): | 39.54 |
Book Value ($): | 11.97 |
Cash Flow ($): | 1.81 |
Price/Earnings (x): | 39.54 |
---|---|
Price/Sales (x): | 2.15 |
Price/Book (x): | 2.28 |
Price/Cash Flow (x): | 19.59 |
Quick Ratio (x): | 0.72 |
---|---|
Current Ratio (x): | 1.77 |
LT Debt/Equity (x): | 44.45 |
Total Debt/Equity (x): | 59.11 |